Exosomes and Hair Regeneration: A Systematic Review of Clinical Evidence Across Alopecia Types and Exosome Sources
Top Cited Papers
Open Access
- 1 September 2025
- journal article
- review article
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 18, 2215-2227
Abstract
Mesenchymal stem cell (MSC)-derived exosomes are recognized a promising cell-free therapy for alopecia. These nano-vesicles facilitate intercellular communication and contain a variety of bioactive molecules that can potentially stimulate hair follicle regeneration. However, the safety and efficacy of exosome therapy for alopecia remains to be determined. This systematic analysis aimed to determine the clinical safety and effectiveness of exosome therapy for hair growth, particularly androgenetic alopecia (AGA) and other forms of hair loss. Systematic searches were conducted on PubMed, Scopus, and Embase databases to find clinical studies published from inception until 10th May 2025 that explored exosome-based interventions for hair loss. Eleven studies included: two RCTs, three retrospective studies, three prospective single-arm studies, one case series, and two case reports. Extracted data included method of preparation, outcomes of hair regrowth (density, thickness, patient satisfaction), and side effects. Quality of evidence was assessed using the Oxford Centre for Evidence-Based Medicine (OCEBM) levels and risk of bias tools (RoB 2 and ROBINS-I). All the studies included demonstrated improvements in at least one hair parameter, with MSC-derived exosomes from adipose tissue, placenta, hair follicles, bone marrow, foreskin, and umbilical cord having substantial increases in hair density (9.5 to 35 hairs/cm²) and hair thickness (up to 13.01 μm). Patient satisfaction was generally high (3– 10 point scales), and no serious adverse events were noted. The greatest level of evidence came from RCTs with adipose- and plant extract–derived exosome formulation. However, heterogeneity in design and outcome limited direct comparisons. Exosome therapy, particularly with MSC-derived sources, appears to be a new and safe treatment modality for hair restoration in AGA and other alopecias. The current evidence is, however, limited by heterogeneity in studies, small sample sizes, and varying follow-up durations. More well-standardized, high-quality RCTs are required to confirm these findings and establish standardized treatment protocols.Keywords
This publication has 23 references indexed in Scilit:
- Treatment of persistent chemotherapy-induced hair loss (Alopecia) with human mesenchymal stromal cells exosome enriched extracellular vesicles: A case reportHeliyon, 2023
- Exosome therapy in hair regeneration: A literature review of the evidence, challenges, and future opportunitiesJournal of Cosmetic Dermatology, 2022
- Clinical Use of Extracellular Vesicles in the Management of Male and Female Pattern Hair Loss: A Preliminary Retrospective Institutional Review Board Safety and Efficacy StudyAesthetic Surgery Journal Open Forum, 2022
- PRISMA2020 : An R package and Shiny app for producing PRISMA 2020‐compliant flow diagrams, with interactivity for optimised digital transparency and Open SynthesisCampbell Systematic Reviews, 2022
- Effects of exosome from adipose‐derived stem cell on hair loss: A retrospective analysis of 39 patientsJournal of Cosmetic Dermatology, 2022
- Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethicsJournal of Cosmetic Dermatology, 2021
- Exosomes in disease and regeneration: biological functions, diagnostics, and beneficial effectsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2020
- Chemotherapy‐induced alopecia management: Clinical experience and practical adviceJournal of Cosmetic Dermatology, 2017
- The Levels of Evidence and Their Role in Evidence-Based MedicinePlastic and Reconstructive Surgery, 2011
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLOS Medicine, 2009